Lunai Bioworks (LNAI) Retained Earnings (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Retained Earnings of -$155698.0 in Q1 2026, down 11.99% quarter-over-quarter from -$139023.0 in Q4 2025, and up 99.96% on a YoY basis from -$77864.8 in Q1 2025.
Lunai Bioworks (LNAI) Retained Earnings (2011 - 2026) Analysis & Trends
Lunai Bioworks' Retained Earnings history runs 16 years deep, the most recent figure standing at -$155698.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.96% year-over-year to -$155698.0; the TTM figure through Mar 2026 stood at -$155698.0 (up 99.96% YoY), while the FY2025 annual figure was -$510.5 million, down 53.54% from the prior year.
- Retained Earnings was -$155698.0 for Q1 2026 at Lunai Bioworks, down from -$139023.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$29882.0 in Q2 2023 to a low of -$510.5 million in Q2 2025.
- Historically, Retained Earnings has averaged -$203.1 million across 5 years, with a median of -$216.5 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings surged 99.97% in 2023, then plunged 1112459.67% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$216.5 million in 2022, then slipped by 19.04% to -$257.7 million in 2023, then jumped by 98.51% to -$3.8 million in 2024, then surged by 96.39% to -$139023.0 in 2025, then retreated by 11.99% to -$155698.0 in 2026.
- The last three Retained Earnings figures came in at -$155698.0 (Q1 2026), -$139023.0 (Q4 2025), and -$507.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -155,698.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155,698.00 |
| Dec 31, 2025 | -139,023.00 |
| Sep 30, 2025 | -507.64 Mn |
| Jun 30, 2025 | -510.46 Mn |
| Mar 31, 2025 | -383.73 Mn |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -376.67 Mn |
| Jun 30, 2024 | -332.46 Mn |
| Mar 31, 2024 | -316.72 Mn |
| Dec 31, 2023 | -257.73 Mn |
| Sep 30, 2023 | -64,483.00 |
| Jun 30, 2023 | -29,882.00 |
| Mar 31, 2023 | -220.83 Mn |
| Dec 31, 2022 | -216.50 Mn |
| Sep 30, 2022 | -212.04 Mn |
| Jun 30, 2022 | -30,436.00 |
| Mar 31, 2022 | -114.11 Mn |
| Dec 31, 2021 | -107.91 Mn |
| Sep 30, 2021 | -101.32 Mn |
| Jun 30, 2021 | -90.91 Mn |